UNSPSC 51433916: Forasartan

This classification denotes an angiotensin ii receptor antagonist with the molecular formula C23H28N8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 065F7WPT0B, chemically known as 5-((3,5-dibutyl-1h-1,2,4-triazol-1-yl)methyl)-2-(2-(1h-tetrazol-5-ylphenyl))pyridine but generally known as forasartan, which bears US NIH Compound Identifier 132706. European Medicines Agency schedules Forasartan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07781MIG.

UNSPSC 51433916 Forasartan is a Commodity code that maps to emergency medical medications and related pharmaceutical supplies that state and local governments purchase for emergency response and public health operations. The recent opportunity block shows state and local buyers acquiring advanced life support medications — including vasopressors, cardiac agents, and related injectables — for fire-rescue operations and emergency medical services. The scope of work under this code spans procurement of branded and generic pharmaceutical products used in acute care settings, typically supplied in unit doses or vials with strict expiration and sterility requirements. Issuing bodies include city purchasing departments, county health agencies, fire departments, and emergency medical services authorities. The Tampa Fire Rescue procurement signals that municipalities and special-purpose districts are the primary market for these medications, with purchasing departments acting as the contracting authority on behalf of operational end-users.

The City of Tampa's Purchasing Department issued IFB 26P00188 in April 2026 for advanced life support medications (Labetalol HCI, Epinephrine, Adenosine, and Diltiazem) with a response deadline of April 8, 2026 and an estimated contract value of $40,000. The solicitation required firm pricing including all freight to Tampa, Florida, a nine-month minimum shelf life from acceptance, delivery within ten calendar days of order, and OSHA-compliant Safety Data Sheets; the contract term was one year with two optional one-year renewals and up to three additional 30-day unilateral extensions. The opportunity carried a 5 percent bid discount for Small Local Business Enterprise participation capped at $10,000. No other state or local opportunities under this code appear in the recent-opportunities block, indicating limited visibility into current activity under the Forasartan commodity code specifically. Florida represents the only jurisdiction with a named recent solicitation; geographic spread across other states and issuing-body concentration cannot be determined from the available source material.